MedTrace Logo

Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women

NCT02224313 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-03-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the vaginal health between premenopausal and postmenopausal women before and after using oral "estradiol" for 14 days then "estradiol" and "progesterone" for 14 days.

Conditions

Interventions

DRUG

oral estradiol 1.0 mg

one tablet of oral estradiol 1.0 mg once a day for 28 days

DRUG

oral progesterone 100 mg

one tablet of oral progesterone 100 mg once a day for 14 days

Sponsors & Collaborators

  • TherapeuticsMD

    collaborator INDUSTRY

  • Intira Sriprasert

    lead OTHER

Principal Investigators

  • David F Archer, MD · Eastern Virginia Medical School

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02224313 on ClinicalTrials.gov